Annals of Emergency Medicine
Volume 36, Issue 3 , Pages 198-203 , September 2000

Continuous Versus Intermittent Nebulization of Salbutamol in Acute Severe Asthma: A Randomized, Controlled Trial

Received 29 October 1999 ,Revised 3 April 2000 ,Accepted 17 May 2000.

References 

  1. National Asthma Education and Prevention Program . Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; July 1997; [NIH publication No. 97-4051]
  2. The British Guidelines on Asthma Management . 1995 review and position statement. Asthma in adults and school children. Thorax. 1997;52:S2–S8
  3. Rossing TH, Fanta CH, Goldstein DH, et al.  Emergency therapy of asthma: comparison of the acute affects of parenteral and inhaled sympathomimetics and infused aminophylline. Am Rev Respir Dis. 1980;122:365–371
  4. High-dose inhaled versus intravenous salbutamol combined with theophylline in severe acute asthma. Swedish Society of Chest Medicine. Eur Respir J. 1990;3:163–170
  5. Salmeron S, Brochard L, Mal H, et al.  Nebulized versus intravenous salbutamol in hypercapnic acute asthma. A multicenter double blind randomized study. Am J Crit Care Med. 1994;149:1466–1470
  6. Browne GJ, Penna AS, Phung X, et al.  Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet. 1997;349:301–305
  7. McFadden ER, Elsanadi N, Dixon L, et al.  Protocol therapy for acute asthma: therapeutic benefits and cost savings. Am J Med. 1995;99:654–661
  8. Strauss L, Hejal R, Galan G, et al.  Observation on the effects of aerosolized albuterol in acute asthma. Am J Respir Crit Care Med. 1997;155:454–458
  9. Peake JE, Mellon AF. Asthma guidelines, burst therapy for acute asthma. BMJ. 1993;306:1341; [letter, comment]
  10. Nelson HS, Spector SL, Witsset TL. The bronchodilator response to inhalation of increasing doses of aerosolized albuterol. J Allergy Clin Immunol. 1983;72:371–375
  11. Britton J, Tattersfield A. Comparison and noncumulative techniques to measure dose-response curves for beta agonists in patients with asthma. Thorax. 1984;39:597–599
  12. Roberston CF, Smith F, Beck R. Response for frequent low doses of nebulized salbutamol in acute asthma. J Pediatr. 1985;106:672–674
  13. Papo MC, Frank J, Thompson AE. A prospective randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med. 1993;21:1479–1486
  14. Rudnitsky GS, Everlein RS, Schoffstall JM, et al.  Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department. Ann Emerg Med. 1993;22:1842–1846
  15. Lin RY, Sauter D, Newmant T, et al.  Continuous versus intermittent albuterol nebulization in the treatment of acute asthma. Ann Emerg Med. 1993;22:1847–1853
  16. Colacone A, Wolkove N, Stern E, et al.  Continuous nebulization of albuterol (salbutamol) in acute asthma. Chest. 1990;97:693–697
  17. Shreshta M, Bidadi K, Gourlay S, et al.  Continuous vs intermittent albuterol, at high and low doses, in the treatment of severe acute asthma in adults. Chest. 1996;110:42–47
  18. Reisner C, Kotch A, Dworkin G. Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized, prospective study. Ann Allergy Asthma Immunol. 1995;75:41–47
  19. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med. 1992;326:862–866
  20. Abroug F, Nouira S, Bchir A, et al.  A controlled trial of nebulized salbutamol and adrenaline in acute severe asthma. Intensive Care Med. 1995;21:18–23
  21. Rodrigo C, Rodrigo G. Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma. Chest. 1998;113:593–598
  22. McFadden ER, Strauss L, Hejal R, et al.  Comparison of two dosage regimens of albuterol in acute asthma. Am J Med. 1998;105:12–17
  23. Emerman CL, Cydulka RK, McFadden ER. Comparison of 2.5 vs 7.5 mg of inhaled albuterol in the treatment of acute asthma. Chest. 1999;115:92–96
  24. Fischl MA, Pitchenik A, Gardner LB. An index predicting relapse and need for hospitalization in patients with acute bronchial asthma. N Engl J Med. 1981;305:783–789
  25. Rodrigo G, Rodrigo C. A new index for early prediction of hospitalization in patients with acute asthma. Am J Emerg Med. 1997;15:8–13
  26. Rodrigo G, Rodrigo C. Early prediction of poor response in acute asthma patients in the emergency department. Chest. 1998;114:1016–1021
  27. Moler FW, Hurwitz ME, Custer JR. Improvement in clinical asthma score and PaCO2 in children with severe asthma treated with continuously nebulized terbutaline. J Allergy Clin Immunol. 1988;81:1101–1109
  28. Portnoy J, Aggarwal J. Continuous terbutaline nebulization for the treatment of severe exacerbation of asthma in children. Ann Allergy. 1988;60:368–371
  29. Lin RY, Smith AJ, Hergenroeder P. High serum albuterol levels and tachycardia in adult asthmatics treated with high-dose continuously aerosolized albuterol. Chest. 1993;103:221–225
  30. Moler FW, Johnson LE, Van Laanen C, et al.  Continuous versus intermittent nebulized terbutaline: plasma levels and effects. Am J Respir Crit Care Med. 1995;151:602–606
  31. Jenne JW, Ahrens RC. Pharmacokinetics of beta-adrenergic compounds. In:  Jenne JW,  Murphy S editor. Drug Therapy for Asthma: Research and Clinical Practice. New York, NY: Dekker; 1987;p. 213–258

☆ Address for reprints: Fekri Abroug, MD, Intensive Care Unit, CHU F. Bourguiba, Monastir 5000, Tunisia; 216 3 460672, fax 216 3 460678; E-mail f.abroug@rns.tn .

PII: S0196-0644(00)60739-4

doi: 10.1067/mem.2000.109169

Annals of Emergency Medicine
Volume 36, Issue 3 , Pages 198-203 , September 2000

Article Tools

* Image Usage & Resolution